Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.

Mansooreh Maadi; Behrooz Ghanbari; Hossein Keyvani; Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Farhad Zamani; Nima Motamed; Hossein Ajdarkosh; Jamshid Vafaeimanesh; Mahmoodreza Khoonsari; Masood Reza Sohrabi; Sima Aten; Azita Azarkeivan; Masoumeh Sadat Eslami; Dhayaneethie Perumal

doi:10.1007/s00705-020-04728-x

Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.

Mansooreh Maadi
, Behrooz Ghanbari
, Hossein Keyvani
, Fahimeh Safarnezhad Tameshkel
, Mohammad Hadi Karbalaie Niya
, Farhad Zamani
, Nima Motamed
, Hossein Ajdarkosh
, Jamshid Vafaeimanesh
, Mahmoodreza Khoonsari
, Masood Reza Sohrabi
, Sima Aten
, Azita Azarkeivan
, Masoumeh Sadat Eslami
, Dhayaneethie Perumal

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2193-2203
Journal	Archives of Virology
Volume	165
Early online date	8 Jul 2020
DOIs	https://doi.org/10.1007/s00705-020-04728-x
Publication status	Published - 31 Oct 2020
Externally published	Yes

Bibliographical note

Note: This work was supported by Iran University of Medical Sciences [grant number: 95-04-128-30299].

Keywords

Biological sciences

Access to Document

10.1007/s00705-020-04728-x

https://doi.org/10.1007/s00705-020-04728-x

Cite this

Maadi, M., Ghanbari, B., Keyvani, H., Safarnezhad Tameshkel, F., Karbalaie Niya, M. H., Zamani, F., Motamed, N., Ajdarkosh, H., Vafaeimanesh, J., Khoonsari, M., Sohrabi, M. R., Aten, S., Azarkeivan, A., Eslami, M. S., & Perumal, D. (2020). Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study. Archives of Virology, 165, 2193-2203. https://doi.org/10.1007/s00705-020-04728-x

@article{e6ae11604a294291a3ca2e605fc2f8e7,

title = "Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.",

keywords = "Biological sciences",

author = "Mansooreh Maadi and Behrooz Ghanbari and Hossein Keyvani and \{Safarnezhad Tameshkel\}, Fahimeh and \{Karbalaie Niya\}, \{Mohammad Hadi\} and Farhad Zamani and Nima Motamed and Hossein Ajdarkosh and Jamshid Vafaeimanesh and Mahmoodreza Khoonsari and Sohrabi, \{Masood Reza\} and Sima Aten and Azita Azarkeivan and Eslami, \{Masoumeh Sadat\} and Dhayaneethie Perumal",

note = "Note: This work was supported by Iran University of Medical Sciences [grant number: 95-04-128-30299].",

year = "2020",

month = oct,

day = "31",

doi = "10.1007/s00705-020-04728-x",

language = "English",

volume = "165",

pages = "2193--2203",

journal = "Archives of Virology",

issn = "0304-8608",

publisher = "Springer",

}

Maadi, M, Ghanbari, B, Keyvani, H, Safarnezhad Tameshkel, F, Karbalaie Niya, MH, Zamani, F, Motamed, N, Ajdarkosh, H, Vafaeimanesh, J, Khoonsari, M, Sohrabi, MR, Aten, S, Azarkeivan, A, Eslami, MS & Perumal, D 2020, 'Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.', Archives of Virology, vol. 165, pp. 2193-2203. https://doi.org/10.1007/s00705-020-04728-x

TY - JOUR

T1 - Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients

T2 - a referral center study.

AU - Maadi, Mansooreh

AU - Ghanbari, Behrooz

AU - Keyvani, Hossein

AU - Safarnezhad Tameshkel, Fahimeh

AU - Karbalaie Niya, Mohammad Hadi

AU - Zamani, Farhad

AU - Motamed, Nima

AU - Ajdarkosh, Hossein

AU - Vafaeimanesh, Jamshid

AU - Khoonsari, Mahmoodreza

AU - Sohrabi, Masood Reza

AU - Aten, Sima

AU - Azarkeivan, Azita

AU - Eslami, Masoumeh Sadat

AU - Perumal, Dhayaneethie

N1 - Note: This work was supported by Iran University of Medical Sciences [grant number: 95-04-128-30299].

PY - 2020/10/31

Y1 - 2020/10/31

KW - Biological sciences

U2 - 10.1007/s00705-020-04728-x

DO - 10.1007/s00705-020-04728-x

M3 - Article

SN - 0304-8608

VL - 165

SP - 2193

EP - 2203

JO - Archives of Virology

JF - Archives of Virology

ER -